BioNexus Gene Lab Income Statement (2018-2025) | BGLC

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Mar2018	Sep2018	Dec2018	Mar2019	Jun2019	Sep2019	Dec2019	Mar2020	Jun2020	Sep2020	Dec2020	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025
Revenue & cost
Revenue	0.27M	0.09M	0.01M	0.03M	0.02M	0.02M	0.05M	3.07M	1.10M	3.09M	4.13M	3.45M	3.09M	3.58M	3.25M	3.03M	2.49M	2.58M	2.84M	2.38M	2.57M	2.55M	2.27M	2.38M	1.97M	2.63M	2.52M	2.14M	2.26M	2.54M
Cost of Revenue	0.01M	0.07M	0.02M	0.02M	0.02M	0.02M	0.02M	2.41M	0.94M	2.57M	3.74M	2.87M	2.62M	2.87M	2.77M	2.67M	2.22M	2.28M	2.50M	2.01M	2.23M	2.20M	2.01M	2.02M	1.69M	2.30M	2.21M	1.79M	1.89M	2.17M
Gross Profit	-0.01M	0.02M	-0.01M	0.01M	0.00M	0.01M	0.03M	0.66M	0.16M	0.52M	0.38M	0.58M	0.47M	0.71M	0.48M	0.36M	0.26M	0.30M	0.34M	0.37M	0.34M	0.35M	0.27M	0.37M	0.29M	0.33M	0.31M	0.34M	0.37M	0.38M
Operating items
Research & Development																								0.01M	0.01M	0.01M	0.02M	0.01M	0.01M	0.01M
Selling, General & Administrative	-0.04M	-0.08M	-0.06M	-0.08M	0.08M	0.06M	0.14M	0.33M	0.22M	0.29M	0.49M	0.30M	0.38M	0.38M	0.18M	0.37M	0.45M	0.42M	0.49M	0.54M	0.81M	3.08M	-1.98M	0.32M	0.56M	0.79M	0.31M	0.39M	0.52M	0.45M
Restructuring Costs								0.33M	0.22M	0.29M	0.49M	0.30M	0.38M	0.41M	0.18M	0.37M	0.45M	0.42M	0.49M	0.54M	0.81M	3.08M	-1.98M	0.32M	0.56M	0.79M	0.31M	0.39M	0.52M	0.45M
Other Operating Expenses																								-1.29M	-0.37M	0.53M	-9.10M	-1.85M	0.14M	0.28M
Operating Expenses	-0.04M	-0.08M	-0.06M	-0.08M	0.08M	0.06M	0.14M	0.66M	0.43M	0.59M	0.99M	0.61M	0.76M	0.80M	0.37M	0.74M	0.91M	0.84M	0.98M	1.07M	1.61M	6.16M	-3.97M	-0.65M	0.76M	2.13M	-8.47M	-1.05M	1.19M	1.19M
Operating Income	0.02M	-0.06M	-0.06M	-0.06M	-0.07M	-0.05M	-0.10M	1.07M	-0.03M	0.24M	-0.00M	0.34M	0.14M	0.37M	0.20M	0.03M	-0.14M	-0.07M	-0.12M	-0.05M	-0.27M	-2.53M	0.26M	-0.08M	0.26M	-1.34M	-0.42M	-0.62M	-0.61M	-0.70M
EBIT	0.02M	-0.06M	-0.06M	-0.06M	-0.07M	-0.05M	-0.10M	1.07M	-0.03M	0.24M	-0.00M	0.34M	0.14M	0.37M	0.20M	0.03M	-0.14M	-0.07M	-0.12M	-0.05M	-0.27M	-2.53M	0.26M	-0.08M	0.26M	-1.34M	-0.42M	-0.62M	-0.61M	-0.70M
Non-operating items
Interest & Investment Income																								0.03M	0.05M	0.04M	0.03M	0.02M	0.03M	0.02M
Other Non Operating Income				0.02M	-0.02M	-0.01M	0.02M	-0.29M	0.04M	0.25M	0.15M	-0.21M	-0.01M	-0.06M	0.04M	-0.07M								0.20M	0.73M	0.47M	0.67M	0.09M	0.21M	0.11M
Non Operating Income																								0.20M	0.73M	0.47M	0.67M	0.09M	0.21M	0.11M
Net income details
EBT	0.02M	-0.06M	-0.06M	-0.06M	-0.07M	-0.05M	-0.10M	1.07M	-0.04M	0.23M	-0.01M	0.34M	0.14M	0.37M	0.20M	0.03M	-0.14M	-0.07M	-0.13M	-0.05M	-0.28M	-2.53M	0.25M	-0.08M	0.25M	-1.34M	-0.42M	-0.62M	-0.62M	-0.71M
Tax Provisions			373.00	-0.00M	0.00M	0.03M	-909.00	860.00	487.00	-492.00	0.17M		0.11M	0.08M	-0.47M	0.01M	-0.00M	0.01M	-0.08M	-0.02M	0.02M	0.08M	-0.10M	-0.02M	0.06M	0.00M	-0.08M
Profit After Tax	0.27M	-0.09M	-0.06M	-0.06M	-0.07M	-0.02M	-0.09M	1.07M	-0.04M	0.23M	-0.17M	0.34M	0.03M	0.30M	0.09M	0.02M	-0.14M	-0.08M	-0.16M	-0.07M	-0.26M	-2.61M	0.31M	-0.10M	0.20M	-1.35M	-0.35M	-0.62M	-0.62M	-0.71M
Equity Income																								0.08M	0.09M	0.07M	-0.17M	0.00M	0.02M
Income from Continuing Operations	0.02M	-0.06M	-0.06M	-0.06M	-0.07M	-0.08M	-0.10M	1.07M	-0.04M	0.24M	-0.18M	0.34M	0.03M	0.30M	0.67M	0.02M	-0.14M	-0.08M	-0.05M	-0.04M	-0.29M	-2.61M	0.35M	-0.06M	0.20M	-1.35M	-0.34M	-0.62M	-0.62M	-0.71M
Consolidated Net Income	0.02M	-0.06M	-0.06M	-0.06M	-0.07M	-0.08M	-0.10M	1.07M	-0.04M	0.24M	-0.18M	0.34M	0.03M	0.30M	0.67M	0.02M	-0.14M	-0.08M	-0.05M	-0.04M	-0.29M	-2.61M	0.35M	-0.06M	0.20M	-1.35M	-0.34M	-0.62M	-0.62M	-0.71M
Income towards Parent Company	0.02M	-0.06M	-0.06M	-0.06M	-0.07M	-0.08M	-0.10M	1.07M	-0.04M	0.24M	-0.18M	0.34M	0.03M	0.30M	0.67M	0.02M	-0.14M	-0.08M	-0.05M	-0.04M	-0.29M	-2.61M	0.35M	-0.06M	0.20M	-1.35M	-0.34M	-0.62M	-0.62M	-0.71M
Net Income towards Common Stockholders	0.01	-0.06M	-0.06M		-0.07M	-0.08M	-0.10M	1.07M	-0.04M	0.24M	-0.18M	0.34M	0.03M	0.30M	0.67M	0.02M	-0.14M	-0.08M	-0.05M	-0.04M	-0.29M	-2.61M	0.35M	-0.10M	0.20M	-1.35M	-0.35M	-0.62M	-0.62M	-0.71M
Additional items
EPS (Basic)	0.00	0.00	0.00		0.00	0.00	0.00	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-0.01	0.00	0.00	-0.02	-0.16	0.02	-0.01	0.01	-0.07
EPS (Weighted Average and Diluted)																							0.02	-0.01	0.11	-0.75	-0.02	-0.04	-0.34	-0.40
Shares Outstanding (Weighted Average)	50.99M	67.38M	66.34M	74.66M	74.66M	80.28M	86.37M	102.73M	102.73M	102.73M	102.92M	171.22M	171.22M	171.22M	171.22M	171.22M	172.98M	14.48M	14.41M	14.48M	14.48M	16.77M	15.88M	17.67M	17.67M	17.97M
Shares Outstanding (Diluted Average)																							15.88M	17.67M	1.77M	1.80M	17.82M	17.97M	1.80M	1.80M
EBITDA	0.27M	-0.08M	-0.10M	-0.04M	-0.09M	-0.03M	-0.07M	0.77M	0.01M	0.48M	-0.02M	0.13M	0.02M	0.24M	0.13M	-0.05M	-0.46M	-0.40M	0.24M	-0.11M	-0.59M	-2.63M	0.43M	-0.31M	0.20M	-0.30M	-1.07M	-0.55M	-0.25M	-0.71M
Interest Expenses													0.00M	-0.00M	-0.00M	0.00M	0.00M	-0.00M	-0.00M	-0.00M	-0.00M	0.00M	0.00M	0.00M	0.00M	0.01M	0.01M	0.00M	0.00M	0.01M
Tax Rate			-0.59%	2.10%	-1.70%	-56.07%	0.95%	0.08%	-1.38%	-0.21%	-2,259.10%		79.30%	20.29%	-240.89%	45.59%	1.16%	-15.03%	58.93%	30.13%	-5.81%	-3.02%	-38.63%	23.98%	21.82%	-0.12%	19.12%

Research Tools

BioNexus Gene Lab Income Statement (2018-2025) | BGLC

Create an account

Sign In

Reset Password